7,343 results match your criteria: "Urticaria Chronic"
Front Immunol
December 2024
Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, China.
Introduction: Chronic urticaria (CU) is not traditionally classified as an allergic disease, but emerging evidence suggests a link to atopy. The quintessential marker of atopy is IgE sensitization, there is scarce information on the IgE sensitization characteristics of CU.
Methods: To investigate IgE sensitization characteristics in CU, and compare them with classic allergic diseases.
Ann Allergy Asthma Immunol
December 2024
University of Miami, Coral Gables, Florida.
Background: Chronic spontaneous urticaria (CSU) is an unpredictable inflammatory skin condition with substantial clinical burden that affects 0.23-0.78% of the United States population.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
Patients' collaboration with healthcare providers, along with their individual dedication to follow medical recommendations, is a crucial component of effective therapy in chronic diseases. If a patient fails to fill their prescription, administers the medication improperly in terms of method and/or dosage, misses follow-up visits, or discontinues the treatment for any reason, these lapses can adversely affect disease management, impairing the effectiveness of symptom relief and prevention of progression and complications. A comparable situation pertains to allergic diseases, which require long-term and consistent treatment to achieve symptom alleviation and control.
View Article and Find Full Text PDFArch Dermatol Res
December 2024
Taibah University, Madinah, Saudi Arabia.
Chronic idiopathic urticaria (CIU) is difficult for patients and healthcare professionals to manage owing to its chronic and unpredictable nature. While the exact cause of CIU is unknown, it is suggested that food allergies may contribute to the development of symptoms. To determine the prevalence of food allergy in patients diagnosed with CIU.
View Article and Find Full Text PDFJ Allergy Clin Immunol
December 2024
Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
Background: Chronic spontaneous urticaria (CSU), a common and debilitating disease, is widely held not to be life-limiting, but the mortality of CSU has not been investigated.
Objective: To assess all-cause mortality in CSU patients, risk for comorbidities that are leading causes of death and impact of guideline-recommended urticaria treatments on mortality rates.
Methods: This is a retrospective population-based cohort study of electronic health records of 272,190 adult CSU patients and 12,728,913 non-urticaria controls from the US Collaborative TriNetx Analytics Network.
Arch Dermatol Res
December 2024
Department of Allergy and Clinical Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
Chronic urticaria is a persistent skin condition characterized by recurrent wheals (hives) and/or angioedema lasting more than six weeks, significantly impacting quality of life and often requiring long-term management. Limited access to costly treatments like omalizumab poses challenges in low-income countries with high healthcare expenses and limited insurance coverage, prompting research into cost-effective dosages for effective management. This study aims to find the most cost-effective dosage for treating chronic urticaria in countries with healthcare affordability challenges.
View Article and Find Full Text PDFQual Life Res
December 2024
Acaster Lloyd Consulting Ltd, London, UK.
Background: The objective of this study was to assess the content validity of the EQ-5D-5L and four bolt-ons: skin irritation, self-confidence, social relationships and sleep, for people with atopic dermatitis (AD) and chronic urticaria (CU).
Methods: Adults with AD or CU in the United Kingdom, with varying levels of severity, participated in either online or in-person semi-structured interviews. During the interviews, participants were first asked about the symptoms and impacts of their condition.
Ann Med
December 2025
Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Objective: To investigate the optic disc changes (ODC) in Chinese patients with -associated autoinflammatory disease (-AID).
Methods: Patients who were diagnosed with -AID at the Department of Rheumatology, Peking Union Medical College Hospital between April 2015 and December 2022 were retrospectively reviewed and analyzed.
Results: A total of 20 patients were enrolled in this retrospective study.
Allergy
December 2024
Central Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China.
Ann Allergy Asthma Immunol
December 2024
Endeavor Health, Evanston, IL, USA. Electronic address:
Background: Chronic spontaneous urticaria (CSU) is frequently associated with severe disease-related symptoms that negatively impact quality of life, but patients and physicians may differ in their opinion on CSU burden.
Objective: To describe the clinical and humanistic burden associated with CSU and level of agreement between patient and physician perceptions for disease burden and treatment satisfaction.
Methods: This cross-sectional, survey-based study of US physicians and their adult patients with CSU included data collected in the Adelphi CSU Disease Specific Programme™ from 2020 to 2021.
Dermatol Ther (Heidelb)
December 2024
Department of Dermatology, University of Southern California, 1441 Eastlake Ave, Ezralow Tower, Suite 5301, Los Angeles, CA, 90033-9174, USA.
Introduction: Chronic urticaria (CU) is frequently a debilitating skin condition characterized by recurrent and spontaneous wheal and flares with significant impact on quality of life. This systematic review examines the impact of CU on sexual health.
Methods: A systematic review using PubMed, Embase, Web of Science, and Cochrane library databases was conducted for articles on sexual health in chronic urticaria.
Immunotargets Ther
December 2024
Chengdu ExAb Biotechnology, LTD, Chengdu, People's Republic of China.
Objective: Studies establish a link between autoimmune factors and chronic spontaneous urticaria (CSU). T cells are crucial in immune-mediated diseases like CSU, and T-cell receptor (TCR) diversity could be pivotal in autoimmune responses. The clinical relevance of TCR variations in CSU is unknown, but understanding them may offer insights into CSU's pathogenesis and treatment.
View Article and Find Full Text PDFAllergy Asthma Clin Immunol
December 2024
Division of Allergy, Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada.
Urticaria (hives) is a common disorder that may be associated with angioedema (swelling that occurs beneath the skin). It is generally classified as acute or chronic, and chronic urticaria is further classified as spontaneous or inducible Second-generation, non-sedating histamine type 1 (H1)-receptor antihistamines represent the mainstay of therapy for both acute and chronic urticaria. Second-line treatment for uncontrolled chronic urticaria includes omalizumab (a monoclonal anti-immunoglobulin E [IgE] antibody).
View Article and Find Full Text PDFIndian J Dermatol
October 2024
From the Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Backgrounds: A large proportion of patients with chronic spontaneous urticaria (CSU) are resistant to a standard dose of antihistamine. Acknowledged biomarkers for identifying these patients have not been determined. The neutrophil/lymphocyte ratio (NLR) has been considered as an important indicator of inflammation in chronic diseases.
View Article and Find Full Text PDFIndian J Dermatol
October 2024
From the Department of Dermatology, Hospital Umum Sarawak, Malaysia.
Autohemotherapy is a commonly used treatment for recalcitrant chronic urticaria in some countries. Herein we report our experience using autologous serum therapy in eight patients with recalcitrant chronic spontaneous urticaria. Autologous serum therapy was initiated weekly for nine weeks followed by every fortnightly.
View Article and Find Full Text PDFAllergy
December 2024
Center for Allergy, Nihon University School of Medicine, Tokyo, Japan.
Front Allergy
November 2024
Allergy Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Chronic spontaneous urticaria (CSU) is defined as the occurrence of hives, angioedema, or both, lasting for more than 6 weeks. The treatment is based on the use of antihistamines, omalizumab, and/or cyclosporine following a stepwise algorithm recommended by international guidelines with a high level of evidence. Nevertheless, management can be challenging as some patients do not respond to the suggested drugs or have difficulties accessing them for various reasons.
View Article and Find Full Text PDFAllergol Int
December 2024
Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
J Asthma
January 2025
Department of Pediatric Allergy and Immunology, Ümraniye Training and Research Hospital, Istanbul, Turkey.
PLoS One
December 2024
Division of Pediatric Pulmonology, Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Purpose: Repeated gadolinium-based contrast agent (GBCA)-enhanced MRIs are crucial in the diagnosis and follow-up of oncologic and chronic disorders in pediatric patients. The aim of the study was to evaluate the frequency and severity of adverse reactions to GBCAs in children after a single vs. multiple GBCA-enhanced abdomen MRIs.
View Article and Find Full Text PDFAsia Pac Allergy
December 2024
Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Ann Dermatol
December 2024
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Allergy Asthma Immunol Res
November 2024
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Purpose: In chronic spontaneous urticaria (CSU), autoimmune thyroid disease is the most common autoimmune comorbidity, and many CSU patients have immunoglobulin (Ig)E or IgG autoantibodies to thyroid peroxidase (TPO). It remains unclear how anti-TPO IgE and IgG autoantibodies are linked to each other and are associated with CSU features, activity, and therapeutic responses.
Methods: CSU patients (n = 146, 92 females, mean age 42.
Allergy Asthma Immunol Res
November 2024
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Korea.
Allergy Asthma Immunol Res
November 2024
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.